Heximax 5 mg (Tablet)

Unit Price: ৳ 10.00 (3 x 10: ৳ 300.00)
Strip Price: ৳ 100.00

Medicine Details

Indications

  • Adjunct in the treatment of all forms of parkinsonism
  • Adjuvant therapy for parkinsonism with levodopa
  • Control of extrapyramidal disorders caused by CNS drugs

Description

  • Direct inhibitory effect upon the parasympathetic nervous system
  • Relaxing effect on smooth musculature

Pharmacology

  • Non-selective muscarinic acetylcholine receptor antagonist
  • Binds with higher affinity to the M1 subtype
  • Higher affinity for central muscarinic receptors in the cerebral cortex
  • Lower affinity for peripherally located receptors
  • May modify nicotinic acetylcholine receptor neurotransmission
  • May lead indirectly to enhanced dopamine release in the striatum

Dosage & Administration

  • Individualized dosage
  • Low initial dose, gradually increased, especially in patients over 60 years
  • May be given before or after meals depending on patient's reaction
  • Preferable to take before meals if tending to dry the mouth excessively
  • Initial therapy for parkinsonism: 1 mg administered on the first day, then increased gradually
  • Range of total daily dosage for idiopathic parkinsonism: 6 to 15 mg
  • Concomitant use with Levodopa
  • Total daily intake is best divided into 3-4 doses

Interaction

  • Additive effects with cannabinoids, barbiturates, opiates, and alcohol
  • Increased sedative effects with alcohol or other CNS depressants
  • Potentiation of anticholinergic effects by MAOIs and tricyclic antidepressants
  • Increased risk of tardive dyskinesia with concomitant administration of anticholinergics and neuroleptics
  • Possible need for dosage reduction of either trihexyphenidyl or levodopa during concomitant therapy

Contraindications

  • Hypersensitivity to trihexyphenidyl
  • Narrow angle glaucoma

Side Effects

  • Dryness of the mouth
  • Blurred vision
  • Dizziness
  • Mild nausea
  • Nervousness
  • Suppurative parotitis
  • Skin rashes
  • Dilatation of the colon
  • Paralytic ileus
  • Psychiatric manifestations such as delusions, hallucinations, and paranoia
  • Cognitive dysfunctions
  • Constipation
  • Drowsiness
  • Urinary hesitancy or retention
  • Tachycardia
  • Dilation of the pupil
  • Increased intraocular pressure
  • Choreiform movements
  • Weakness
  • Vomiting
  • Headache
  • Exacerbation of parkinsonism with abrupt treatment withdrawal
  • Neuroleptic malignant syndrome with abrupt treatment withdrawal
  • Angle-closure glaucoma
  • Paradoxical sinus bradycardia
  • Dry skin
  • Cycloplegia
  • Hyperkinesia (in pediatric patients)
  • Psychosis (in pediatric patients)
  • Forgetfulness (in pediatric patients)
  • Weight loss (in pediatric patients)
  • Restlessness (in pediatric patients)
  • Chorea (in pediatric patients)
  • Sleep alterations (in pediatric patients)

Pregnancy & Lactation

  • Use during pregnancy only when clearly needed and benefit outweighs risk
  • Caution in administration to nursing women due to potential for suppression of lactation

Precautions & Warnings

  • Gonioscope evaluation and monitoring of intraocular pressures for patients to be treated with trihexyphenidyl
  • Potential for angle closure and increase in intraocular pressure
  • Caution in hot weather, especially when given with other atropine-like drugs
  • Potential for anhidrosis and hyperthermia, especially in the presence of pre-existing sweating disturbance
  • Potential occurrence of Neuroleptic Malignant Syndrome with dose reduction or discontinuation of trihexyphenidyl

Overdose Effects

  • Typical central symptoms of atropine intoxication
  • Peripheral signs of parasympathetic blockade
  • Neuropsychiatric signs such as delirium, seizures, confusion
  • Treatment involves symptomatic and supportive therapy, gastric lavage, respiratory support

Therapeutic Class

  • Antiparkinson drugs

Storage Conditions

  • Store at temperature not exceeding 30°C
  • Store in a dry place
  • Protect from light

Related Brands